Hanmi Pharmaceutical
Founded in 1973, Hanmi Pharmaceutical is one of Korea’s leading R&D-driven biopharmaceutical companies, committed to creating innovative medicines that improve human health and quality of life.
Guided by our core philosophies of Respect for Humanity and Value Creation, Hanmi has built a strong track record of pharmaceutical innovation and global partnerships with leading pharmaceutical companies.

Our R&D focuses on areas with significant unmet medical needs, including cardiovascular and metabolic diseases, diabetes, obesity, oncology, autoimmune diseases, and rare diseases, with a strong commitment to developing first-in-class and best-in-class therapies.

Backed by world-class manufacturing and quality capabilities, Hanmi continues to expand its global presence while pursuing Trust-Based Management founded on transparency and integrity.

Driven by Creation, Challenge, and Innovation, Hanmi is shaping the future of healthcare through bold and meaningful innovation.